Logo image of ALFEN.AS

ALFEN N.V. (ALFEN.AS) Stock Fundamental Analysis

AMS:ALFEN - Euronext Amsterdam - NL0012817175 - Common Stock - Currency: EUR

10.78  +0.25 (+2.42%)

Fundamental Rating

4

Taking everything into account, ALFEN scores 4 out of 10 in our fundamental rating. ALFEN was compared to 56 industry peers in the Electrical Equipment industry. While ALFEN seems to be doing ok healthwise, there are quite some concerns on its profitability. ALFEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALFEN had negative earnings in the past year.
ALFEN had a positive operating cash flow in the past year.
ALFEN had positive earnings in 4 of the past 5 years.
ALFEN had a positive operating cash flow in each of the past 5 years.
ALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

ALFEN has a worse Return On Assets (-7.45%) than 71.43% of its industry peers.
ALFEN has a worse Return On Equity (-17.74%) than 69.64% of its industry peers.
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ALFEN.AS Yearly ROA, ROE, ROICALFEN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Gross Margin of ALFEN (31.09%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALFEN has declined.
ALFEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
ALFEN.AS Yearly Profit, Operating, Gross MarginsALFEN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

ALFEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALFEN has about the same amount of shares outstanding.
ALFEN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALFEN has been reduced compared to a year ago.
ALFEN.AS Yearly Shares OutstandingALFEN.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALFEN.AS Yearly Total Debt VS Total AssetsALFEN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ALFEN has an Altman-Z score of 2.45. This is not the best score and indicates that ALFEN is in the grey zone with still only limited risk for bankruptcy at the moment.
ALFEN's Altman-Z score of 2.45 is fine compared to the rest of the industry. ALFEN outperforms 76.79% of its industry peers.
ALFEN has a debt to FCF ratio of 1.59. This is a very positive value and a sign of high solvency as it would only need 1.59 years to pay back of all of its debts.
ALFEN has a Debt to FCF ratio of 1.59. This is amongst the best in the industry. ALFEN outperforms 89.29% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that ALFEN is not too dependend on debt financing.
ALFEN's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. ALFEN outperforms 69.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Altman-Z 2.45
ROIC/WACCN/A
WACC7.26%
ALFEN.AS Yearly LT Debt VS Equity VS FCFALFEN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALFEN has a Current Ratio of 1.68. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.68, ALFEN perfoms like the industry average, outperforming 53.57% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that ALFEN may have some problems paying its short term obligations.
With a Quick ratio value of 1.00, ALFEN perfoms like the industry average, outperforming 51.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1
ALFEN.AS Yearly Current Assets VS Current LiabilitesALFEN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for ALFEN have decreased strongly by -191.15% in the last year.
ALFEN shows a decrease in Revenue. In the last year, the revenue decreased by -3.34%.
Measured over the past years, ALFEN shows a very strong growth in Revenue. The Revenue has been growing by 27.79% on average per year.
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%

3.2 Future

ALFEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.73% yearly.
The Revenue is expected to grow by 3.62% on average over the next years.
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y45.73%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y3.62%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALFEN.AS Yearly Revenue VS EstimatesALFEN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
ALFEN.AS Yearly EPS VS EstimatesALFEN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALFEN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 15.80 indicates a correct valuation of ALFEN.
Based on the Price/Forward Earnings ratio, ALFEN is valued a bit cheaper than the industry average as 60.71% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.33, ALFEN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 15.8
ALFEN.AS Price Earnings VS Forward Price EarningsALFEN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALFEN indicates a rather cheap valuation: ALFEN is cheaper than 94.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.5
EV/EBITDA N/A
ALFEN.AS Per share dataALFEN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALFEN's earnings are expected to grow with 101.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y184.12%
EPS Next 3Y101.07%

0

5. Dividend

5.1 Amount

ALFEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALFEN N.V.

AMS:ALFEN (7/15/2025, 7:00:00 PM)

10.78

+0.25 (+2.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-20 2025-08-20
Inst Owners40.9%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap234.47M
Analysts46.67
Price Target12.52 (16.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.64%
PT rev (3m)-20.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)8.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.8
P/S 0.48
P/FCF 7.5
P/OCF 4.2
P/B 1.54
P/tB 1.87
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)0.68
Fwd EY6.33%
FCF(TTM)1.44
FCFY13.33%
OCF(TTM)2.57
OCFY23.81%
SpS22.42
BVpS7
TBVpS5.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.09%
FCFM 6.41%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Debt/EBITDA N/A
Cap/Depr 93.52%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1
Altman-Z 2.45
F-Score5
WACC7.26%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y45.73%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y3.62%
EBIT growth 1Y-172.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year726.38%
EBIT Next 3Y136.35%
EBIT Next 5Y67.49%
FCF growth 1Y207.54%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y890.24%
OCF growth 3Y74.32%
OCF growth 5Y31.69%